Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Co

Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial. is a phase 2/3, randomised interventional study registered as NCT07537998 by Pei-Rong Ding, with a registry enrolment figure of 160 participants, started 2026-04-10 and due to reach its primary completion in 2027-04-10. Interventions recorded: intestinal fluid infusion; potable water. Conditions listed: Low Anterior Resection Syndrome; Rectal Cancer. Primary outcome: LARS score(m1). Colorectal eligibility wording from the registry: "* Patients with mid to low rectal cancer (within 10cm of the anal verge) who undergo radical DIXON+ileostomy surgery". Sites: China. No results are recorded here; the registry entry is the source.